Are Visual Outcomes After Cataract Surgery Different in Diabetic Patients Compared with Non-Diabetic Patients?: A Retrospective Study in a Tertiary Hospital in Saudi Arabia Authors: Naif Alruwais, Shahad F Altayash, Rizwan Malik, Syed J Raheman Published: 2026 ABSTRACT BackgroundCataract surgery is a common procedure that dramatically improves visual clarity. The outcomes for patients with diabetes can be sensitive to various health conditions such as diabetic retinopathy and macular edema. This investigation set out to evaluate and compare post-cataract surgery visual acuity outcomes between diabetic and non-diabetic controls and to evaluate relevant structural and surgical parameters.MethodsThis retrospective observational study was conducted at King Khaled Eye Specialist Hospital (KKESH), where 200 eyes (100 diabetic patients and 100 non-diabetic patients) who were treated with phacoemulsification during October and November 2025 were included. Best-corrected visual acuity (BCVA), central macular thickness (CMT), macular edema and surgical results were examined in the analysis.ResultsNo statistically significant differences in postoperative BCVA were observed between diabetic and non-diabetic patients at one month (0.56 ± 0.39 vs 0.51 ± 0.42 logMAR, p = 0.338) or at final follow-up (0.44 ± 0.41 vs 0.43 ± 0.44 logMAR, p = 0.698). However, diabetic patients demonstrated significantly higher rates of postoperative macular edema (19.0% vs 6.0%, p = 0.005) and greater CMT values (289.17 ± 142.37 µm vs 253.81 ± 67.92 µm, p = 0.026). Progression of diabetic retinopathy was observed in 4% of diabetic eyes during follow-up. No statistically significant association was identified between surgeon experience level and postoperative visual outcomes or complication rates.ConclusionAlthough visual acuity outcomes after cataract surgery are similar in diabetic and non-diabetic patients, those with diabetes show a greater prevalence of macular structural changes. It is recommended to conduct thorough preoperative evaluations and postoperative monitoring for macular complications in diabetic patients. Introduction Cataracts are characterized by the clouding of the lens or its surrounding capsule. This condition can arise from the accumulation of opaque lens fibers or from a deterioration process that affects normally clear lens fibers. Cataracts are a leading cause of blindness worldwide.1 The occurrence of diabetes mellitus has increased significantly and is anticipated to affect 33% of the adult population in the United States by the year 2050.2 Key factors that significantly contribute to diminished visual outcomes are the presence of pre-existing diabetic retinopathy and macular edema.3 Diabetic retinopathy is characterized by the gradual deterioration of the retinal blood vessels due to prolonged high blood sugar levels, leading to damage to the neural retina. The initial visible changes in diabetic retinopathy, which can be seen during an eye exam, are microaneurysms, and these are regarded as a key indicator of non-proliferative diabetic retinopathy (NPDR).4 In diabetic patients, cataracts can impair vision and complicate retinal exams, making cataract surgery potentially beneficial for both diagnostic and therapeutic reasons. Diabetics often develop cataracts earlier and are 2 to 5 times more affected than non-diabetics, leading to more frequent early surgeries. Beyond improving vision, cataract surgery may facilitate the assessment and management of diabetic retinopathy.5 Over the past decades, cataract surgery has undergone Significant advancements that have significantly improved patient outcomes. In contrast, for the patients in diabetes population the advent of small incision phacoemulsification to remove extracapsular cataracts have decreased the wound size, accelerated recovery hours and decreased complications rates.3 Over the past decades, cataract surgery has undergone significant advancements that have markedly improved surgical safety and visual outcomes. Modern phacoemulsification techniques, smaller surgical incisions, improved fluidics, and enhanced intraocular lens designs have contributed to faster visual recovery and lower complication rates. Despite these advancements, diabetic patients remain at increased risk of postoperative retinal complications, particularly diabetic macular edema and progression of diabetic retinopathy, which may affect long-term visual outcomes.6 These novel approaches together highlight the progression of cataract surgery into an internationally standardized and safe surgical platform, which provides reliable visual rehabilitation across heterogeneous groups of patients. In-vivo imaging and intravitreal anti VEGF therapies have provided advance in diabetic retinopathy management.7 It was indicated that diabetic patients experience positive outcomes in visual acuity following cataract surgery.8 The results of cataract surgery in individuals with diabetes are generally promising, exhibiting high reliability, although there is a marginally elevated risk of complications compared to those without diabetes.8 Low preoperative visual acuity, advanced diabetic retinopathy, and older age may contribute to decreased postoperative visual acuity. However, despite comparable postoperative visual acuity outcomes, it remains unclear whether similar visual recovery reflects equivalent retinal structural health in diabetic and non-diabetic patients.9,10 This study aims to compare visual acuity and central macular thickness post-operative between groups, and also to investigate the impact of glycemic control and surgeon experience on a specific period of time. The rationale for the study of this cohort is that its clinical uncertainty over whether similar visual postoperative acuity indeed describes equivalent retinal health in diabetic patients is warranted, given our patients’ higher likelihood of developing macular edema and retinopathy. Materials and Methods Study Design and Setting This retrospective observational study was performed at King Khaled Eye Specialist Hospital (KKESH), a tertiary eye care center in Riyadh, Saudi Arabia, between January 2014 and December 2024. Study Population Consecutive eligible patients who underwent phacoemulsification cataract surgery during the study period were retrospectively identified through the hospital’s electronic medical records system. Sample Size Calculation A total of 200 patients (100 per group) were included. The Sample size was calculated assuming a two-sided α=0.05, 80% power, equal allocation, and a common postoperative VA SD of 0.30 logMAR, which indicated that a sample of ~99 per group were required to detect a 0.12 logMAR difference in postoperative visual acuity between diabetics and non-diabetics using the two-sample means formula n=2(Zα/2+Zβ)2σ2δ2 n=δ22(Zα/2+Zβ)2σ2. Eligibility Criteria Patients aged 40 or more who had cataract surgery in combination with both diabetics and non-diabetics were included in the study. For eligibility, documented visual acuity data prior to and postoperatively were required, with a minimum duration of 3 months postoperatively. In contrast, patients were excluded if they had pre-existing ocular conditions that could impact visual acuity (such as advanced glaucoma or retinal detachment), a history of prior intraocular surgery aside from cataract extraction, incomplete medical records, or significant corneal opacities that could hinder visual improvement. Data Collection Data were extracted from electronic medical records during October and November 2025. The gathered data encompassed baseline characteristics (including demographics, medical background, diabetes status, hypertension, and preoperative HbA1c levels), operative data, and postoperative outcomes (specifically best-corrected visual acuity (BCVA) assessed preoperatively, at one month, and at the final evaluation). Snellen visual acuity measurements were converted to logarithm of the minimum angle of resolution (logMAR) values for statistical analysis. Data collection also included optical coherence tomography (OCT) readings, such as central macular thickness, the presence of macular edema, the advancement of diabetic retinopathy, details of the surgical procedure, surgeon grade, and any complications that arose post-surgery. Ethical Consideration This retrospective analysis received approval from the Institutional Review Board (IRB) at King Khaled Eye Specialist Hospital (KKESH) under project number 25,193-R on September 1, 2025. The study followed the Declaration of Helsinki and was conducted in compliance with ethical standards for retrospective research. Data were retrieved from the hospital’s electronic medical record system (TrackCare), the standardized platform used at King Khaled Eye Specialist Hospital for patient documentation and follow-up. Statistical Analysis Standard descriptive and inferential statistical techniques were used to analyze the data. Means ± standard deviations were used to summarize continuous variables, and frequencies and percentages were used to present categorical variables. The independent t-test for continuous variables and the chi-square test for categorical variables were used to compare the diabetes and non-diabetic groups. Statistical significance was defined as a p-value of less than 0.05. Based on the presence of diabetes and the degree of surgeon expertise, visual results, macular structural parameters, and postoperative complications were compared between the groups. The association between preoperative HbA1c and final postoperative BCVA was demonstrated using Box and Whisker Plot. Results Study Population and Baseline Findings Study involved 200 eyes from 200 patients, including 100 diabetic and 100 non-diabetic patients undergoing cataract surgery. Table 1 explains the baseline characteristics of the study population. The diabetic patients had a were older than the non-diabetic patients (68.67 ± 8.20 vs 65.55 ± 14.57 years) and these differences were not statistically significant (p = 0.063). The male patient proportion was comparable between the groups (52.0% in diabetic patients vs 42.0% in non-diabetic patients, p = 0.157). Among diabetics, hypertension was much more prevalent compared to non-diabetics (67.0% vs 43.0%, p = 0.001). As anticipated, HbA1c values were significantly higher in the diabetic individuals (8.34 ± 2.40% vs 5.89 ± 0.72%, p < 0.001). Preoperative best-corrected visual acuity (BCVA) was similar between diabetic and non-diabetic patients (0.90 ± 0.42 vs 0.95 ± 0.54 logMAR, p = 0.896), suggesting a comparable baseline visual status pre-operatively.Table 1Baseline Characteristics of Eyes Undergoing Cataract Surgery by Diabetic Status (n = 200)VariableNon-diabetic (n = 100)Diabetic (n = 100)p-valueAge, years65.55 ± 14.5768.67 ± 8.200.063Male gender, n (%)42 (42.0%)52 (52.0%)0.157Hypertension, n (%)43 (43.0%)67 (67.0%)0.001HbA1c, %5.89 ± 0.728.34 ± 2.40<0.001Preoperative BCVA (code)0.95 ± 0.540.90 ± 0.420.896 Table 1Baseline Characteristics of Eyes Undergoing Cataract Surgery by Diabetic Status (n = 200)VariableNon-diabetic (n = 100)Diabetic (n = 100)p-valueAge, years65.55 ± 14.5768.67 ± 8.200.063Male gender, n (%)42 (42.0%)52 (52.0%)0.157Hypertension, n (%)43 (43.0%)67 (67.0%)0.001HbA1c, %5.89 ± 0.728.34 ± 2.40<0.001Preoperative BCVA (code)0.95 ± 0.540.90 ± 0.420.896 Baseline Characteristics of Eyes Undergoing Cataract Surgery by Diabetic Status (n = 200) Postoperative Visual Outcomes Postoperative visual outcomes are summarized in Table 2. At one month after surgery, postoperative BCVA was not significantly different between diabetic and non-diabetic patients (0.56 ± 0.39 vs 0.51 ± 0.42 logMAR, p = 0.338). Similarly, final postoperative BCVA values were comparable between the two groups (0.44 ± 0.41 vs 0.43 ± 0.44 logMAR, p = 0.698). The proportion of eyes achieving functional visual acuity (VA ≥20/40) was 50.0% in diabetic eyes and 57.0% in non-diabetic eyes (p = 0.321).Table 2Visual Outcomes by Diabetic StatusOutcomeNon-diabetic (n = 100)Diabetic (n = 100)p-value1-month BCVA (code)0.51 ± 0.420.56 ± 0.390.338Final BCVA (code)0.43 ± 0.440.44 ± 0.410.698Achieved VA ≥20/40, n (%)57 (57.0%)50 (50.0%)0.321 Table 2Visual Outcomes by Diabetic StatusOutcomeNon-diabetic (n = 100)Diabetic (n = 100)p-value1-month BCVA (code)0.51 ± 0.420.56 ± 0.390.338Final BCVA (code)0.43 ± 0.440.44 ± 0.410.698Achieved VA ≥20/40, n (%)57 (57.0%)50 (50.0%)0.321 Visual Outcomes by Diabetic Status Macular Structural Outcomes Macular structural outcomes evaluated by optical coherence tomography (OCT) are summarized in Table 3. Mean central macular thickness was significantly greater in diabetic than in non-diabetic eyes (289.17 ± 142.37 µm vs 253.81 ± 67.92 µm, p = 0.026). Macular edema was more common among diabetic eyes (19.0%) compared with non-diabetic eyes (6.0%) (p = 0.005). Diabetic retinopathy progression at follow-up was found to be observed for 4% of diabetic eyes and no progression was seen in non-diabetic eyes (p = 0.043). Despite comparable visual acuity outcomes, diabetic patients demonstrated significantly greater macular structural abnormalities postoperatively.Table 3OCT and Macular Outcomes by Diabetic StatusVariableNon-diabetic (n = 100)Diabetic (n = 100)p-valueCMT (µm)253.81 ± 67.92289.17 ± 142.370.026Macular edema, n (%)6 (6.0%)19 (19.0%)0.005Progression of diabetic retinopathy, n (%)0 (0.0%)4 (4.0%)0.043 Table 3OCT and Macular Outcomes by Diabetic StatusVariableNon-diabetic (n = 100)Diabetic (n = 100)p-valueCMT (µm)253.81 ± 67.92289.17 ± 142.370.026Macular edema, n (%)6 (6.0%)19 (19.0%)0.005Progression of diabetic retinopathy, n (%)0 (0.0%)4 (4.0%)0.043 OCT and Macular Outcomes by Diabetic Status Postoperative Outcomes and Surgical Experience Postoperative outcomes according to surgeon experience level are summarized in Table 4. No statistically significant association was identified between surgeon experience level and final postoperative BCVA (0.46 ± 0.44 vs 0.43 ± 0.39 vs 0.39 ± 0.41 logMAR for consultant, resident, and fellow groups, respectively; p = 0.541). Similarly, the proportion of eyes achieving functional visual acuity (VA ≥20/40) did not differ significantly across surgeon groups (50.5%, 53.3%, and 59.0%, respectively; p = 0.562). The overall complication rates were also comparable between consultant, resident, and fellow surgeon groups (39.4%, 36.7%, and 42.6%, respectively; p = 0.849). The documented operative and postoperative complications included posterior capsular rupture, postoperative corneal edema, elevated intraocular pressure, postoperative inflammatory reactions, and wound-related complications. Most complications were transient and managed conservatively during follow-up.Table 4Surgical Experience and Postoperative OutcomesSurgeon LevelEyes, nFinal BCVA (Code), mean ± SDVA ≥20/40, n (%)Any Complication*, n (%)Consultant1090.46 ± 0.4455 (50.5%)43 (39.4%)Resident300.43 ± 0.3916 (53.3%)11 (36.7%)Fellow610.39 ± 0.4136 (59.0%)26 (42.6%)p-value—0.5410.5620.849 Table 4Surgical Experience and Postoperative OutcomesSurgeon LevelEyes, nFinal BCVA (Code), mean ± SDVA ≥20/40, n (%)Any Complication*, n (%)Consultant1090.46 ± 0.4455 (50.5%)43 (39.4%)Resident300.43 ± 0.3916 (53.3%)11 (36.7%)Fellow610.39 ± 0.4136 (59.0%)26 (42.6%)p-value—0.5410.5620.849 Surgical Experience and Postoperative Outcomes Suboptimal Visual Outcomes Among eyes that did not achieve functional visual acuity (VA ≥20/40), postoperative macular edema, diabetic retinopathy progression, and operative or postoperative complications were the most frequently documented contributing factors. Diabetic eyes demonstrated higher rates of postoperative macular edema (19.0% vs 6.0%) and greater central macular thickness values, which were associated with less favorable visual recovery. Diabetic retinopathy progression was observed exclusively among diabetic patients during follow-up (4.0%). Visuals and Glycaemic Control Figure 1 illustrates postoperative visual improvement (ΔlogMAR) among diabetic patients stratified according to HbA1c category (<7%, 7–8.9%, and ≥9%). Similar distributions of visual improvement were observed across the different glycemic control groups.Figure 1Postoperative visual improvement (ΔlogMAR) stratified by HbA1c category among diabetic patients (<7%, 7–8.9%, ≥9%), showing the distribution of visual acuity improvement after cataract surgery. Positive values indicate improvement. Black dots represent outlier values in the boxplot.A box plot showing visual improvement by hemoglobin A1c category. Postoperative visual improvement (ΔlogMAR) stratified by HbA1c category among diabetic patients (<7%, 7–8.9%, ≥9%), showing the distribution of visual acuity improvement after cataract surgery. Positive values indicate improvement. Black dots represent outlier values in the boxplot. Discussion Cataract surgery in patients with diabetes is clinically important because diabetic eyes may be more susceptible to postoperative retinal complications, particularly macular edema and progression of diabetic retinopathy.8 In this retrospective study, postoperative visual acuity outcomes following cataract surgery were comparable between diabetic and non-diabetic patients. However, diabetic eyes demonstrated significantly higher rates of postoperative macular edema, greater central macular thickness (CMT), and progression of diabetic retinopathy during follow-up. No statistically significant differences in postoperative BCVA were observed at one month or at the final follow-up between the two groups. These findings are consistent with large-scale studies, including the ACCORD Eye Study, which demonstrated that cataract surgery generally provides favorable visual outcomes in diabetic patients when advanced retinopathy or significant macular pathology is absent.10 Large national cataract surgery databases have similarly reported that approximately 84%–91% of patients achieve postoperative BCVA of 20/40 or better, with rates approaching 95% in patients without additional ocular comorbidities.11,12 Previous comparative studies have also shown that diabetic patients may achieve visual outcomes comparable to those of non-diabetic patients, particularly when preoperative macular status is stable.13,14 The relatively lower proportion of eyes achieving functional visual acuity in the present cohort may reflect the tertiary referral nature of the study population, which included patients with coexisting retinal pathology, diabetic retinal disease, and postoperative macular structural abnormalities. Despite similar visual acuity recovery between the groups, diabetic patients demonstrated significantly higher rates of postoperative macular edema (19% vs 6%) and increased CMT.15 These findings are consistent with previous reports demonstrating that diabetes is associated with an increased risk of pseudophakic macular edema, with reported incidence rates ranging from 10% to 20% depending on glycemic control and the severity of diabetic retinopathy.16 Furthermore, a recent Bayesian network meta-analysis demonstrated that prophylactic interventions, including topical nonsteroidal anti-inflammatory drugs (NSAIDs) and intravitreal anti-VEGF therapy, may reduce the risk of postoperative macular edema in diabetic eyes.17 Previous studies have also shown that diabetic patients who develop postoperative macular edema tend to experience less favorable visual recovery following cataract surgery.18 These findings underscore the importance of careful perioperative macular assessment and close postoperative retinal monitoring in diabetic patients undergoing cataract surgery. Importantly, comparable postoperative visual acuity outcomes do not necessarily indicate equivalent retinal structural recovery. Another important finding was that progression of diabetic retinopathy during follow-up was observed in 4% of diabetic eyes.19 These findings further support the need for continued retinal surveillance following cataract surgery in diabetic patients. Previous studies have similarly suggested that cataract surgery may accelerate the progression of diabetic retinopathy, particularly in eyes with pre-existing non-proliferative diabetic retinopathy (NPDR).20 In addition, the Chennai Urban Rural Epidemiology Eye Study demonstrated that longer duration of diabetes and poor metabolic control are associated with increased diabetic retinal disease burden.21 No statistically significant association was identified between surgeon experience level and postoperative visual outcomes or complication rates within this cohort. These findings may reflect the standardized nature of modern phacoemulsification techniques and perioperative surgical protocols used at the institution. Previous systematic reviews have similarly suggested that postoperative outcomes in diabetic patients are influenced more by underlying ocular comorbidity than by surgeon experience alone.22 This study aimed to compare postoperative visual outcomes between diabetic and non-diabetic patients following cataract surgery and to evaluate the relationship between visual acuity outcomes and postoperative macular structural changes. Although postoperative visual acuity outcomes were comparable between the two groups, diabetic patients demonstrated higher rates of postoperative macular edema, increased CMT, and progression of diabetic retinopathy, suggesting greater postoperative retinal structural susceptibility. These findings support the importance of careful preoperative macular assessment, optimization of glycemic control, and close postoperative retinal monitoring in diabetic patients undergoing cataract surgery. Future multicenter studies with larger sample sizes and longer follow-up periods may help validate these findings and further optimize perioperative retinal management strategies in diabetic patients undergoing cataract surgery. Several limitations should be considered when interpreting the findings of this study. The retrospective design may have introduced selection bias and limited the availability of detailed longitudinal retinal data. Information regarding previous retinal treatments, including pan-retinal photocoagulation and intravitreal therapy, was not consistently available in all medical records and therefore could not be reliably incorporated into subgroup analyses. In addition, preoperative OCT measurements were not consistently available for all patients, limiting detailed structural comparison before and after surgery. Consequently, the primary OCT analysis focused on postoperative macular structural status and postoperative macular edema rather than longitudinal retinal thickness changes. Furthermore, the duration of follow-up may not fully reflect long-term visual and retinal outcomes in diabetic patients. As this study was conducted at a single tertiary referral center with a relatively limited sample size, the generalizability of the findings may be limited. Unmeasured confounding variables and unobserved determinants of surgical response may also have influenced postoperative outcomes. Conclusion Cataract surgery resulted in comparable postoperative visual acuity outcomes between diabetic and non-diabetic patients in this cohort. However, diabetic eyes demonstrated higher rates of postoperative macular edema, greater central macular thickness, and diabetic retinopathy progression, suggesting increased retinal structural vulnerability despite similar functional visual recovery. Careful perioperative retinal assessment and postoperative monitoring remain important in diabetic patients undergoing cataract surgery.